Precision Medicine

Novel Childhood Cancer Genes Identified

Researchers have identified a range of genetic features that could provide us with novel drug targets and greater understanding of over 20 different types of childhood cancer.

IVF Drug Shows Promise in Phase 3 Trial

ObsEva has proved successful in producing topline data from a phase 3 trial of nolasiban, a drug designed to improve the pregnancy rate of in vitro fertilization procedures. 

Introducing the Canadian Genomics Cloud

This public cloud computing platform, the first of its kind in Canada, promises to give every scientist in the country unfettered access to technology empowering precision medicine and other applications in genome research.

Putting Patients On Chips

Technology Integrates stem cells from patients into a new approach to predict most effective disease treatments based on a patient’s unique biology.